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Oral cancer is one of the most common neoplasm’s and is ranked eighth in the cancer incidence worldwide. Early
detection is of critical importance because survival rates markedly improve. In vivo staining is a simple, inexpensive,
and fairly sensitive method. Involved 120 patients (50 with Premalignant Lesion, 50 with OSCC and 20 controls)
stained by Methylene Blue (MB). The results of MB uptake were compared with a simultaneous biopsy of these
lesions. Pathologically confirmed precancers and cancers were the positive targets of this screening, while
hyperkeratosis without dysplasia and no evidence of malignancy were sorted as negative subjects of screening. The
results revealed sensitivity of 91.4%, specificity of 66.6%, positive predictive value 97.7% and negative predictive
value 33% leading to diagnostic accuracy of MB stain to 90%. We state that MB staining is useful diagnostic tool in
community oral cancer screening programmes for high-risk individuals.
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Oral cavity cancer accounts for approximately 3% of all
malignancies and is a significant worldwide health prob-
lem (Kademani 2007; Silverman 2001). Most oral ma-
lignancies occur as squamous cell carcinomas; despite
remarkable advances in treatment modalities, the 5-year
survival rate has not significantly improved over the
past several decades and still hovers at about 50–60%
(Ries et al. 2999). Oral squamous cell carcinoma (OSCC)
is one of the most common neoplasm and it is ranked
eighth in the cancer incidence worldwide, with an an-
nual incidence rate of 64,460. However total number of
cases at any given time will be 2.5 to 3 times higher than
this number (Mehta & Hamner 1993).
Many OSCCs develop from premalignant lesions &
conditions of the oral cavity (Silverman et al. 1984;
Silverman 1968). A wide array of conditions have been
implicated in the development of oral cancer, including
leukoplakia, erythroplakia, palatal lesion of reverse cigar
smoking, oral submucous fibrosis, discoid lupus erythe-
matosus, and hereditary disorders such as dyskeratosis
congenita and epidermolysis bullosa (Warnakulasuriya* Correspondence: malskam@gmail.com
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in any medium, provided the original work is pet al. 2007). Despite the general accessibility of the oral
cavity during physical examination, many malignancies
are not diagnosed until late stages of disease. In order to
prevent malignant transformation of these precursor le-
sions, multiple screening and detection techniques have
been developed to address this problem. The early de-
tection of cancer is of critical importance because sur-
vival rates markedly improve when the oral lesion is
identified at an early stage (Ries et al. 2999). Periodic
clinical examination of the oral cavity is the key to early
detection of oral cancer (Ya-Wei 2007a). Among the
diagnostic tool, in vivo staining is advocated as a simple,
inexpensive and fairly sensitive method (Ya-Wei 2007b).
Methylene Blue (MB) has been used to detect gastric,
prostrate and bladder cancers (Mufti et al. 1990; Gill
et al. 1984; Yu et al. 1990). In the diagnosis, accuracy of
the MB technique is used for identification of intestinal
metaplasia, carcinoma or dysplasia. In one of the studies,
its validity in detection of oral cancer and precancerous
lesion has also been examined. The exact mechanism for
the uptake of methylene blue in epithelial tissue may re-
semble that of toluidine blue in the acidophilic charac-
teristic of cells with abnormal concentration of nucleic
acid, resulting in differential uptake between normal/
benign and highly dysplastic /malignant cells. The 90%
sensitivity of MB was no less than 72–100% sensitiveOpen Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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toxicity and cheaper prices, methylene blue may be con-
veniently substituted for large scale screening in high
risk patients (Ya-Wei 2007a). Methylene blue is a com-
monly used stain that helps us see microscopic life in
brilliant color. The dye, methylene blue shows the dee-
pest shade of blue, indicating a strong attraction to acids
including DNA.
In the present paper an attempt has been made to
establish MB as an early diagnostic marker in the sus-
pected cases of oral precancerous lesions and oral squa-
mous cell carcinoma for wider screening programmes.
Methods
Subjects
The study group consisted of 120 subjects of both the
sexes, 50 subjects with clinically suspicious premalignant
lesions, 50 subjects with clinically suspicious oral can-
cers and 20 cases of subjects with clinically appearing
normal mucosa. A provisional diagnosis of leukoplakia,
erythroplakia, smoker’s palate (premalignant lesions) and
Oral cancer were made on basis of clinical examination.
Patient’s more than or equal to 15 yrs of age, with the
habit of smoking and/or tobacco consumption were
made part of the study. Patients with age less than 15
years, immunocompromised states, with premalignant
conditions, and patients with diabetes or other systemic
disorders were excluded from the study. Ethics commit-
tee approval from the college ethics committee was ta-
ken for the smooth conduct of the study. (CPGIDSH/09).
Controls were subjects with clinically normal appearing
oral mucosa. The subjects were made to sit comfortably
on the dental chair and were thoroughly examined under
artificial illumination. The clinical examination was done
and the relevant data was entered into the proforma.
Gargling solution
Methylene blue dye system had 2 solution bottles. The
dye rinse solution (Bottle A) had 1% methylene blue, 1%
malachite, 0.5% eosin, glycerol, and dimethylsulfoxide.
Pre- and post-rinse solution (Bottle B) had 1% lactic
acid, and purified water.
Staining procedure
The application of methylene blue was as follows. The
patients were directed to rinse their mouth with 1% lac-
tic acid & distilled water for 30 seconds to remove food
debris and excess saliva and to provide a consistent oral
environment. The mucosa of the target area was gently
dried with gauze and power air spray to ensure that the
lesion was not being contaminated with saliva. The dye
was directly applied on the lesion with help of cotton
bud (Mufti et al. 1990) first and after used as a mouth
rinse gargle (Ya-Wei 2007a) with Methylene blue for30 seconds; then expectorated. Patients then rinsed again
with 1% lactic acid for 30 seconds to wash out the excess
dye (Ya-Wei 2007a). The pattern of dye retention was
assessed by the intensity of stain retention on the lesion.
Local, and deep blue stains were marked as positive (+)
reaction. Wide, shallow or faint blue stains were marked
as negative (–) reaction (Ya-Wei 2007a). The results of
methylene blue dye staining were recorded with photo-
graphs and incisional biopsy was performed simultan-
eously in the suspected lesions to compare the accuracy of
the diagnostic capability of methylene blue.
Biopsy
Incisional biopsy was performed in the most obvious
staining area of the suspected lesion of the patient under
local anaesthesia. The specimen was then fixed in 10%
neutral buffered formalin and processed in the oral path-
ology laboratory for initial routine pathologic diagnosis.
Histological examination
All the specimens were microscopically evaluated by pa-
thologists who were blind to the results of methylene
blue stain. The pathology reports of the lesions were
classified as A) Oral Precancerous: Mild, Moderate and
Severe Dysplasia B) Oral Cancer: Well, Moderately and
Poorly differentiated Squamous Cell Carcinoma C) Le-
sions neither precancerous nor malignant: Hyperkera-
tosis without dysplasia and No evidence of malignancy.
The results were then deduced and were statistically an-
alyzed using the various statistical tests given below and
the final results were drawn.
Statistical analysis
The pathologically proven OSCC and precancerous le-
sions were the targets of screening and the concerned is
presented by number and percentage of the same. The
results of positive/negative uptake of methylene blue in
each lesion were correlated with the histopathological
diagnosis. Statistical analysis was performed, including
sensitivity, specificity, positive and negative predictive
values. The association of methylene blue uptake and
pathologic diagnosis among the precancers/ OSCC group,
lesions neither premalignant nor malignant group, nor
normal group were analyzed using Fisher’s exact test
(Wilson 1927). A p value (probability value) of less than
0.01 was considered very significant. The statistical ana-




120 subjects (50 with Premalignant Lesion, 50 with OSCC
and 20 controls) were enrolled in this study. The patient’s
ages (patient group) ranged from 15 yrs to 80 yrs, with the
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history of tobacco consumption. The suspected lesions
were distributed over the buccal mucosa (n = 84), palate
(n = 6), tongue (n = 4), floor of the mouth (n = 2). In the
control group, as methylene blue dye was not used to
examine the oral cavity, it was necessary to verify that the
dye would not be retained on normal mucosa. The results
demonstrated that there was no retained dye in the con-
trol group.
Methylene blue staining related to grade of pathology
The Clinical and Histological characteristics of the vari-
ous study Groups are shown in Table 1. The pathologic
grade was classified as precancer lesions, oral cancer le-
sions, hyperkeratosis without dysplasia and no evidence
of malignancy. The following statistical terms were used
to describe and analyze the relationship between the
grade of pathology and the uptake of methylene blue
staining. Sensitivity represents the proportion of histo-
logically proved cancer/precancerous lesions which are
detected by positive methylene blue staining. In the
current study, 44 of 48 pathologically proven cancers
and 42/46 precancerous lesions were positive with deep
and focal methylene blue staining (Figure 1A,B,C,
Figure 2A,B,C). The overall sensitivity was 91.4%.
Specificity suggests the proportion of pathologic be-
nign lesions, neither precancerous lesions nor cancers,
which are correctly identified as negative staining of
methylene blue. In our study, 4 out of 6 cases with no
dysplasia or malignancy showed negative staining; thus,
the specificity was 66.6%. The results of staining with
methylene blue for all lesions correlated well with theTable 1 Clinical and histological characteristics of the various
Criteria Group I
Premalignant lesions (n = 50)
Age≤ 40 yrs 28 56%
≥40 yrs 22 44%
Sex Females 2 4%
Males 48 96%
Site Buccal Mucosa(BM) 40 leukoplakia
Palate 4 smoker’s palate
Tongue 2 leukoplakia
Floor of mouth
Tobacco Use No 0
Yes 50




without dysplasiapathologic diagnosis and are summarized in Table 2.
Fisher’s exact test showed significant differences among
cancer/precancerous lesions, lesions without dysplasia or
malignancy, and normal control groups (p < 0.001).
Overall, the positive predictive value was 97.7%, and the
false predictive value was 33.3%.
Overall diagnostic validity of methylene blue stain
Out of 100 lesions, 88 (92%) lesions retained methylene
blue stain while 12 (8%) lesions failed to retain the stain.
Out of these 88 methylene blue stained lesions, 86 were
histologically proved as having either dysplastic or car-
cinomatous change, while 2 (2%) were diagnosed as
hyperkeratosis without dysplasia / no evidence of malig-
nancy. Out of 12 unstained lesions 8 were histopatho-
logically diagnosed as carcinomatous while 4 were
diagnosed as hyperkeratosis without dysplasia / no evi-
dence of malignancy respectively. The sensitivity of
methylene blue in determining dysplastic and carcin-
omatous changes was determined as 91.4% while the
specificity was determined as 66.6%, the positive predict-
ive value 97.7%., the negative predictive value 33.3%.
The overall diagnostic value of methylene blue stain in
distinguishing premalignant and malignant lesion 90%
The p value less than <0.001 which is indicates that
these results are stastically very significant.
Discussion
Oral Cancer is very common in a country like India due
to habits of smoking and chewing tobacco containing
pan masala. Tobacco consumption is the main etiologic
factor inducing carcinogenesis in oral mucosa. WHOstudy groups
Group II Group III
OSCC (n = 50) Controls (n = 20)
8 16% 12 60%
42 84% 8 40%
14 28% 4 20%
36 72% 16 80%






WDSCC 30 60% —
MDSCC 16 32%
PDSCC 2 4 %
No evidence of 2 4%
Malignancy
Figure 1 Presentation of a true-positive staining on a red and white homogenous patch on the right buccal mucosa. (A) The lesion
presented clinically as a red and white homogenous patch. (B) Vital staining with methylene blue showed deep and focal staining of the lesion.
(C) The final pathology revealed a severe dysplasia. (H &E, 40×).
Figure 2 Presentation of a true-positive staining on the floor of the mouth. (A) The lesion presented clinically as a huge growth on the
floor of the mouth with indurated margins. (B) Vital staining with methylene blue showed deep and focal staining of the lesion. (C) The final
pathology revealed a moderately differentiated squamous cell carcinoma. (H &E, 40×).
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Table 2 Diagnostic accuracy of methylene blue in the study groups
Methylene Blue
Retention
Histological diagnosis Overall (PML + SCC)





+ 42 1 44 1
− 4 3 4 1
Sensitivity 91.3% 91.6% 91.4%
Specificity 75% 50% 66.6%
Positive predictive value 97.6% 97.7% 97.7%
Negative Predictive Value 42.8% 20% 33.3%
Diagnostic Accuracy 90% 90% 90% p < 0.0001(very significant)
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which 220 will be due to tobacco use. A survey by
WHOSEA (Women’s Health in South East Asia) has in-
dicated that almost 50% of oral cancer in men and 25%
cases of women in India are believed to be tobacco-
borne (Mehta & Hamner 1993). Thus oral screening of
high-risk individuals is very important in these countries.
Amongst the various diagnostic tools, in vivo staining is
advocated as simple and sensitive method for early de-
tection of oral cancer (Ya-Wei 2007b).
For a large scale community screening, some dye ma-
terials easily help to identify abnormal mucosa tissue
which raise oral examiners attention and refer the pa-
tients with suspicious lesions to oral surgeons for further
examination. Toluidine Blue has been championed in
many parts of world for several decades as a means of
identifying clinically occult lesions in patients whose oral
mucosa may otherwise be normal that is as a screening
test or adjunct (Mashberg 1983). The efficacy of this
technique has been evaluated in many reports with diverse
results. It has yielded sensitivities between 72–100% and
specificities between 45–67% in detecting suspicious ma-
lignancies (Epstein et al. 1997; Onofre et al. 2001; Epstein
et al. 1992; Warnakulasuriya & Johnson 1996). However
the material data safety sheet indicates that toluidine blue
is probably toxic by ingestion and is seldom used in
detecting cancers in other parts of body (Ya-Wei 2007a).
Methylene blue is another recently proposed dye for
in vivo staining used in endoscopic examination (Bruno
2003). Its application has been reported recently in detec-
ting some gastrointestinal abnormalities such as Barrett’s
esophagus (Canto et al. 1996; Canto et al. 2000), gastric
cancer (Canto et al. 2000), prostate cancer (Mufti et al.
1990; Gill et al. 1984) bladder Methylene blue (MB) is an
acidophilic dye, it binds to the double helical DNA with a
high affinity, as deduced from the absorption and fluores-
cence spectral data. Extensive hypochromism and red
shifts in the absorption spectra were observed when MB
binds to calf thymus DNA (CT DNA), which suggestedthe intercalation mechanism of MB into DNA bases.
Upon binding to DNA, the fluorescence from MB was ef-
ficiently quenched by the DNA bases, with no shifts in the
emission maximum. The large increases in the polariza-
tion upon binding to CT DNA supported the intercalation
of MB into the helix (Wen-You et al. 2000). The binding
of methylene blue to DNA and chromatin treated in vari-
ous ways was also examined by equilibrium dialysis. The
maximum r value (moles of bound dye/mole of nucleo-
tide) was 1.0 for DNA, 0.6 for unfixed chromatin, and
0.83 for chromatin fixed in methanol-acetic acid104. All
these studies have established the fact that methylene
show proportionate binding to DNA nucleotide and this
accounts for increase in intensity of stain color with in-
crease in chromatin material in premalignant and malig-
nant cells.
Very few studies have been conducted till now to es-
tablish the usage of methylene blue technique in detec-
ting oral precancerous/cancerous lesions8. Screening
studies should always be evaluated with respect to their
sensitivity, specificity and predictive values (Lingen et al.
2008). Although there is no defined value for the ideal
screening test but in general, it is desirable to have both
high specificity (few false positives) and high sensitivity
(few false negatives) (Lingen et al. 2008). In the present
study, the pool of 100 patients (50 cancerous, 50 precan-
cerous) were screened against 20 control (normal sub-
jects) and we found that 88/94 pathologically proven
precancers/cancerous lesions showed positive staining
with localized and deep blue stain. Overall 91.4% sensi-
tivity (91.3% for premalignant and 91.6% for OSCC) was
reported with a false negative rate of 8.6%. Previous
studies have indicated sensitivity of 72–100% (Epstein
et al. 1997; Onofre et al. 2001; Epstein et al. 1992;
Warnakulasuriya & Johnson 1996) in others and 90% in
oral screening (Ya-Wei 2007a), on the basis of these and
our studies we can say that using methylene blue dye for
diagnostic screening is highly acceptable. For few false
negatives results, we consider that ambiguous faint blue
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but clinically suspicious of malignancy, are proved pa-
thologically after biopsy. As far as specificity is con-
cerned we obtained overall specificity of 66.6% (4/6)
(75% in premalignant and 50% in OSCC) with a resul-
ting 2 false positives, that were the cases of chronic un-
healed ulcers. The high false positives rate was discussed
to be related to the retention of stain in inflamed and
trauma areas (Mashberg 1983). Other factors can be ir-
regular, papillary or digital surfaces of the lesions, which
may cause the mechanical retention of dye, contami-
nation of saliva and plaque, retention of dye material in
papilla of the tongue or minor salivary gland ducts over
the mucosa (Ya-Wei 2007a).
Applying this method for screening high risk patients
having habits of tobacco chewing or smoking, a large
group of individuals may include those with obvious oral
lesions and those with normal oral mucosa. To study
these people and to re-evaluate the efficacy of lesions, a
large population of the people with normal oral mucosa
will lower the rate of false positives and result in higher
specificity as found on our case where when compared
with control (n = 20) false positives were 0 and specifi-
city was 100% although our control group was having
normal mucosa but the flaw in our experimental design
was that these subjects were not having any type of to-
bacco chewing or smoking habits, as we cannot screen
individuals with these habits and no lesions because
performing biopsy in normal mucosa will be unethical.
Thus we can say that this study has established methy-
lene blue as a diagnostic agent (with diagnostic accu-
racy of 90% and stastically very significant results with
p-value < 0.001) for early detection of cancerous and pre-
cancerous lesions. This dye will be convenient to substi-
tute for toluidine blue because of its non-toxicity and
low cost. However pathology report based on biopsy will
always remain gold standard to exactly and accurately
diagnose the lesion before a treatment modality is deter-
mined (Mashberg 1980).
Staining should be routinely used as a method to
assist the choice of biopsy site and in the follow up
of premalignant lesions and in the experienced hands
marginal demarcation of the malignant lesions enables
an intervention method to be adopted earlier for the
diseases, which carries a high rate of morbidity and
mortality. Further study is recommended to study the
exact binding mechanism of methylene blue in pre-
cancerous, cancerous, benign and normal mucosa to
establish this dye as the efficient diagnostic tool for diag-
nosing and differentiating between different pathological
conditions.Competing interest
The author declares that they have no competing interest.Authors’ contributions
AR carried out the practical work of the study, BS gave expert comments
and provided help in framing the study and the manuscript. MK drafted the
manuscript and conceptualized the idea of the study. SN participated in
drafting of the manuscript. All authors read and approved the final
manuscript.
Received: 3 January 2013 Accepted: 25 February 2013
Published: 9 March 2013
References
Bruno MJ (2003) Magnification endoscopy, high resolution endoscopy, and
chromoscopy; towards a better optical diagnosis. Gut 52(Suppl 4):iv7–iv11, 5
Canto MI, Setrakian S, Petras RE et al (1996) Methylene blue selectively stains
intestinal metaplasia in Barrett’s esophagus. Gastrointest Endosc 44:1–7
Canto MI, Setrakian S, Willis J et al (2000) Methylene blue-directed biopsies
improve detection of intestinal metaplasia and dysplasia in Barrett’s
esophagus. Gastrointest Endosc 51:560–568
Epstein JB, Scully C, Spinelli J (1992) Toluidine blue and Lugol’s iodine application
in the assessment of oral malignant disease and lesions at risk of
malignancy. J Oral Pathol Med 21:160–163
Epstein JB, Oakley C, Millner A, Emerton S, van der Meij E (1997) The utility of
toluidine blue as s a diagnostic aid in patients previously treated for upper
oropharyngeal carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod
83(5):537–547
Gill WB, Huffman JL, Lyon ES, Bagley DH, Schoenberg HW, Straus FH 2nd (1984)
Selective surface staining of bladder tumors by intravesical methylene blue
with enhanced endoscopic identification. Cancer 53:2724–2727
Kademani D (2007) Oral cancer. Mayo Clin Proc 82(7):878–887
Lingen MW, Kalmar JR, Karrison T, Speight PM (2008) Critical evaluation of
diagnostic aids for the detection of oral cancer. Oral Onc 44:10–22
Mashberg A (1980) Re-evaluation of toluidine blue application as a diagnostic
adjunct in the detection of asymptomatic oral squamous carcinoma. Cancer
46:758–763
Mashberg A (1983) Final evaluation of tolonium chloride rinse for screening of high-
risk patients with asymptomatic squamous carcinoma. JADA 106:319–323
Mehta FS, Hamner JE (1993) Tobacco related oral mucosal lesions and conditions
in India. Tata Inst. of Fundamental, Research
Mufti GR, Shah PJ, Parkinson MC, Riddle PR (1990) Diagnosis of clinically occult
bladder cancer by in vivo staining with methylene blue. Br J Urol 65:173–175
Onofre MA, Sposto MR, Navarro CM (2001) Reliability of toluidine blue
application in the detection of oral epithelial dysplasia and in situ and
invasive squamous cell carcinomas. Oral Surg Oral Med Oral Pat Oral Radiol
Endod 91:535–540
Ries LAG, Melbert D, Krapcho M, Stinchcomb DG, Howlader N, Horner MJ,
Mariotto A, Miller BA, Feuer EJ, Altekruse SF, Lewis DR, Clegg L, Eisner MP,
Reichman M, Edwards BK (2999) SEER cancer statistics review, 1975-2005.
National Cancer Institute, Bethesda, MD, http://seer.cancer.gov/csr/1975_
2005/, based on November 2007 SEER data submission, posted to the SEER
web site, 2008 [database online]. 2008. Updated 2008
Silverman S Jr (1968) Observations on the clinical characteristics and natural
history of oral leukoplakia. J Am Dent Assoc 76(4):772–777
Silverman S Jr (2001) Demographics and occurrence of oral and pharyngeal
cancers. The outcomes, the trends, the challenge. J Am Dent Assoc
132:7S–11S
Silverman S Jr, Gorsky M, Lozada F (1984) Oral leukoplakia and malignant
transformation. A follow-up study of 257 patients. Cancer 53(3):563–568
Warnakulasuriya KA, Johnson NW (1996) Sensitivity and specificity of OraScanW
toluidine blue mouthrinse in the detection of oral cancer and precancer.
J Oral Pathol Med 25:97–103
Warnakulasuriya S, Johnson NW, Van der Waal I (2007) Nomenclature and
classification of potentially malignant disorders of the oral mucosa. J Oral
Pathol Med 36(10):575–580
Wen-You L, Jin-Gou X, Xi-Wen H (2000) Characterization of the binding
of methylene blue to DNA by spectroscopic. Methods Anal Letters
33(12):2453–2464
Wilson EB (1927) Probable inference, the law of succession, and statistical
inference. J Am Stat Assoc 22:209–212
Ya-Wei C (2007a) Application of in vivo stain of methylene blue as a diagnostic
aid in the early detection and screening of oral squamous cell carcinoma
and precancerous lesion. J Chin Med Assoc 70:497–503
Riaz et al. SpringerPlus 2013, 2:95 Page 7 of 7
http://www.springerplus.com/content/2/1/95Ya-Wei C (2007b) Methylene blue as a diagnostic aid in the early detection
of oral cancer and precancerous lesion. Br J Oral Maxillofac Surg
45:590–591
Yu DS, Chang SY, Ma CP (1990) Photoinactivation of bladder tumor cells by
methylene blue: study of a variety of tumor and normal cells. J Urol
144(1):164–168
doi:10.1186/2193-1801-2-95
Cite this article as: Riaz et al.: Methylene blue as an early diagnostic
marker for oral precancer and cancer. SpringerPlus 2013 2:95.Submit your manuscript to a 
journal and beneﬁ t from:
7 Convenient online submission
7 Rigorous peer review
7 Immediate publication on acceptance
7 Open access: articles freely available online
7 High visibility within the ﬁ eld
7 Retaining the copyright to your article
    Submit your next manuscript at 7 springeropen.com
